Here is the reference for the above topic. I have collected the maximum information that i got from the internet. If any one need the complete information comment here.
(Rocky) Jaipur Call Girl - 9001626015 Escorts Service 50% Off with Cash ON De...
genetic variations and its role in health/ pharmacology
1. GENETIC VARIATIONS AND ITS ROLE IN HEALTH /
PHARMACOLOGY
Department of pharmacology
Under the guidance of
Vivek Kumar Tiwari
(M.Pharm)
Submitted by,
M.Srivani
(Regd No: 1702-18-887-014)
GOKARAJU RANGARAJU COLLEGE OF PHARMACY
(Affiliated to Osmania University)
Bachupally, Nizampet Road
Hyderabad -500090.
2. CONTENTS
• What are genetic variations?
• Why genetic variation is important?
• Examples
• Mechanisms of genetic variations
• Causes
• Sources
• Factors affecting
• Role in health/ pharmacology
• Advances in genetic variations
8. 1. GENETIC FACTORS
A) SEXUAL REPRODUCTION
Crossing over
Random mating/ Independent assortment
Random fertilization
B) MUTATIONS
2. ENVIRONMENTAL FACTORS
9. SOURCES OF GENETIC VARIATION
1. MUTATIONS
- Causes
A) DNA fails to copy accurately
B) External influences can create mutations
- Types
10. 2. MEIOTIC DIVISIONS 3. SEXUAL REPRODUCTION
Male + Female gametes (haploid cell)
46 chromosomes in haploid gametes
(23 in each)
Each gene has 2 alleles (223)
8 million possible chromosome
combinations (223)
Fertilization (ovum + sperm)
(223 * 223)
1 to 70 trillion possibilities
11. 4. ERRORS IN CHROMOSOME
SEGREGATION
5. HORIZONTAL ACQUISITION OF
GENES
Replication of genetic material (no equal
chromosome segregation)
No equal distribution in daughter cells
Abnormal number of chromosomes in
daughter cell (ploidy changes)
Example: Down syndrome is caused due
to trisomy of chromosome21.
12. FACTORS AFFECTING GENETIC VARIATION
1. Mating partners are important
2. Random forces lead to genetic drift
3. Distribution
4. Migration
ROLE IN HEALTH/ PHARMACOLOGY
1. Gene replacement and gene addition
2. DNA and RNA targeting and delivery methods
3. Gene therapy
4. Genetic testing
5. Gene repair therapies
6. Viral vectors or vehicles used to transfer DNA and RNA
13. 1. Gene replacement and gene addition
Apolipoprotein E (ApoE) is a blood
circulating protein with pleiotropic
(many effects) atheroprotective
properties that has emerged as a strong
candidate for treating
hypercholesterolemia and
cardiovascular disease.
2. DNA and RNA targeting and delivery
methods
• Receptors are proteins located on the
surface of the cell DNA
• Ex-vivo insulin production
• Catheterization of organ surgical
methods
• Antigens are proteins located on the
surface of the cell DNA
14. 3. Gene therapy
• Replacing mutated genes
• Fixing mutated genes
• Making diseased cells more
evident to the immune system
4. Gene testing
• Molecular genetic tests
• Chromosomal genetic tests
• Biochemical genetic tests
15. 5. Gene repair therapies
• DNA repair is a collection of
processes by which a cell identifies and
corrects damage to the DNA molecules
that encode its genome.
• CRISPR–Cas9, parts of a genome can
be edited by scientists by removing,
adding, or altering parts in a DNA
sequence.
6. Viral vectors or vehicles used to
transfer DNA and RNA
Retroviruses, adenovirus, adeno-
associated virus, herpesvirus and
poxvirus are employed in more than
70% of clinical gene therapy trials
16. ADVANCES IN GENETIC VARIATIONS
1. Genetics of congenital heart defects
Homocystein (hyperhomocysteinemia)
Excitation causes due to release of glutamate, aspartate
That leads to trauma, stroke, stress
Also leads to atherosclerosis
De novo mutations causes nearly 10% CHD
Genome scanning methods for studying CHD
2. Disease-related genes play a role in pain responding
Pain may increase with disease severity or disease induced pain
2 genes responsible arte CASP-9, encodes for caspase 9 involved in programmed cell death
Place major role in lumbar discogenic disease
17. 3. Delivery of RNA therapeutics
CRISPR-Cas9 (stretococcus pyogenes)
In-vitro delivery Ex-vivo editing
Correct mutations in DMD, heriditary
Tyrosynemia type 1, liver diseases, decrease
Blood cholesterol levels.
(PCSK9 knockout)
Editing with spcas9 trigger
haemopoietic stem cells to correct
sickle cell anemia
This is due to mutation in gene coding
β-globin
Deplete CCR5 to trigger anti HIV or to
deplete PD-1 to boost anti cancer
therapy
Limitations:
a) Inperfect DNA targeting
b) Low efficiency of genome editing
18. 4. Gene editing technology
Gene finger nucleases + Cas/CRISPRs + TALENS
Destroy and repair without genotoxicity
Used in hematological diseases and to destroy malignant cell and to achieve proliferating
cells activity
CART Gene therapy is applied to B cell malignancies
5. Genetic Testing and Treatment of Neonatal Diabetes Mellitus
Sulphonylurea treatment to decrease NDM before genetic diagnosis is available
Genetic diagnosis detects single-nucleotide, testing of all NDM genes that alters treatment
method
19. 6. Herpes vector gene delivery - two strategies useful
Sterotactic inoculation Peripheral inoculation
into neural parenchyma
Parkinsons and spinal root trauma
Peripheral inoculation to transduce
sensory neurons to treat neuropathy/ pain
Created BCL-2 or GDNF vectors
Florogold beads injected into CNS,
then translocated & injected into
substantia nigra
Vectors injected with 6-OH dopamine
and activity is studied
20. 7. Mutations in CCR5 gene protects against AIDS
C-C chemokine receptor type 5 (CCR5) is a key player in HIV infection
binding to the virus and leading to the entry and spread of HIV
scientists targetted CCR5 molecule to prevent HIV infection in-vivo
anti-HIV humoral responses through CCR5 targeting
21. REFERENCES
1. Types of mutations- frameshift, chromosomal and point mutation.
https://www.biotecharticles.com/Genetics-Article/Types-of-Mutations-Frameshift-
2. Understanding evolution.
https://evolution.berkeley.edu/evolibrary/article/0_0_0/evo_16
3. The Genetic Variation in a Population Is Caused by Multiple Factors.
https://www.nature.com/scitable/topicpage/the-genetic-variation-in-a-population-is-
6526354
4. Recent advances in understanding the genetics of congenital heart defects, Bruce D.
Gelb, M.D. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4049978/
5. Genetic Basis of Pain Variability: Recent Advances. Erin E. Young, William R.
Lariviere, and Inna Belferhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC3821734/.
6. Viruses as gene delivery vectors: Application to gene function, target validation, and
assay development. Michael T Lotze & Thomas A Kost.
https://www.nature.com/articles/7700493
7. Current status and recent advances of gene therapy in hematological diseases.
Masato Yamamoto, Kenzaburo Tani
8. Recent Advances in Genetic Testing and Treatment of Neonatal Diabetes Mellitus.
Banu Küçükemre Aydın Feyza Darendeliler.
https://academic.oup.com/jcem/article/100/1/L13/2835564
22. 9. Gene therapy progress and prospects: targeted gene repair. H Parekh-Olmedo, L Ferrara,
E Brachman & E B Kmiec. https://www.nature.com/articles/3302511
10. Therapies targeting DNA and RNA in Huntington's disease.
Wild EJ1, Tabrizi SJ2.
11. CCR5: From Natural Resistance to a New Anti-HIV Strategy, Lucia Lopalco.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3185609/